1. In week 26, seasonal influenza activity remained low nationally.
2. In clinical laboratories, 1.0% of respiratory specimens tested positive for influenza, with a distribution of Influenza A(H1N1)pdm09, A(H3N2), and B viruses.
3. Outpatient respiratory illness visits accounted for 1.4% of healthcare visits, which is below the national baseline.
4. ILI activity varied by jurisdiction, with no moderate, high, or very high activity reported.
5. Geographic spread of influenza activity showed local activity in four states and sporadic activity in the majority of states.
6. The hospitalization rate for laboratory-confirmed influenza was 0.1 per 100,000 population.
7. Pneumonia and influenza mortality was 0.02% of deaths, below the epidemic threshold.
8. Three influenza-associated pediatric deaths were reported during week 26, bringing the total to 184 deaths for the season.
9. Virologic surveillance monitored influenza virus characterization, highlighting the genetic and antigenic properties and antiviral susceptibility of circulating viruses.
10. CDC recommends annual flu vaccination and the use of antiviral drugs for treating flu illness.
11. The CDC provides additional national and international influenza surveillance information through various resources and collaborations.